THCB

Categories

Tag: Jennifer Schneider

The Applied Health Signals Category of Health Tech | Jennifer Schneider, Livongo

• 1

BY JESSICA DAMASSA, WTF HEALTH

Before Livongo set digital health records for its IPO, it started 2019 by launching a brand-new category of healthcare company: the Applied Health Signals company. How is this category different than what we already think of when we think about digital health and healthcare? How is it distinct from health tech’s other emerging classification, digital therapeutics? Jennifer Schneider, Livongo’s President, explains why the company started the new category, which is intended for those who are working at the intersection of data science, clinical impact, and behavioral outcomes. Could your company be an Applied Health Signals Company? Listen in to hear Jenny talk about how Livongo’s “AIAI engine” drove the decision to start the new classification. If your tech works like hers…maybe you are!

Filmed at HLTH 2019 in Las Vegas, October 2019.

Continue reading…

Health in 2 Point 00, Episode 81 | Takeover, Take Two with Jenny Schneider

Today on Health in 2 Point 00, we have another takeover! Dr. Jennifer Schneider, president of Livongo, is here to give us her take on health tech news. On Episode 81, Jess asks Jenny about Daye, a startup developing cramp-fighting CBD tampons, which just raised $5.5 million, and LetsGetChecked, which raised $30 million for at-home health testing. Jess also asks about Jenny’s new book, Decoding Health Signals, which offers a blueprint for building a consumer-focused healthcare company.

Health in 2 Point 00, Episode 63 Walgreens & Fedex partnership, Verily’s adherence program, & more!

• 1

Today on Health in 2 Point 00, Jess and I get festive for the holidays. In this episode, Jess asks me about Walgreens and its new partnership with FedEx for next day prescription delivery and with Verily to help patients with prescription adherence. She also asks me about blockchain startup PokitDok getting its assets acquired by Change Healthcare. Lots of job changes are happening as well. Amy Abernethy, the chief medical officer at Flatiron Health, was named Deputy Commissioner of the FDA. Rasu Shrestha, who was previously at the University of Pittsburgh Medical Center, is the new chief strategy officer of Atrium Health. Finally, Zane Burke, who recently stepped down as president of Cerner, was just hired as Livongo’s new CEO, while Glen Tullman remains executive chairman of the company. Dr. Jennifer Schneider was also promoted from the company’s chief medical officer to president. We have one more episode of Health in 2 Point 00 for 2018, so be on the lookout for our year-end wrap-up. —Matthew Holt